thiotepa has been researched along with Inflammatory Breast Cancer in 1 studies
Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| VanderWalde, A | 1 |
| Ye, W | 1 |
| Frankel, P | 1 |
| Asuncion, D | 1 |
| Leong, L | 1 |
| Luu, T | 1 |
| Morgan, R | 1 |
| Twardowski, P | 1 |
| Koczywas, M | 1 |
| Pezner, R | 1 |
| Paz, IB | 1 |
| Margolin, K | 1 |
| Wong, J | 1 |
| Doroshow, JH | 1 |
| Forman, S | 1 |
| Shibata, S | 1 |
| Somlo, G | 1 |
1 trial available for thiotepa and Inflammatory Breast Cancer
| Article | Year |
|---|---|
Long-term survival after high-dose chemotherapy followed by peripheral stem cell rescue for high-risk, locally advanced/inflammatory, and metastatic breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Combined | 2012 |